Carolina Aguilar is  Co-Founder & CEO of INBRAIN Neuroelectronics, a BCI therapeutics company pioneering precision neurology through the development of graphene brain interfaces with ultra-high density and resolution with the mission to decode neural signals to improve people’s lives

She has over 20 years of expertise in healthcare out of which she was 13 years in the European Headquarters of Medtronic in Switzerland, leading globally businesses in brain modulation and diabetes where she managed complex markets and large teams that generated high YoY growth and innovation. Carolina is passionate about creating solutions that improve the outcomes that matter to patients and drive healthcare sustainability. She won several awards and honors, such as the European Value Based Health Care Prize and the PMEA Patient Centricity Award, for delivering patient-centric and value-based models of care. Just recently INBRAIN got FDA breakthrough designation for their innovative neural platform and delivered the world’s first application of a graphene-based neural interface in humans. The company also won the Most Innovative Company of the Year in 2022